Literature DB >> 25011714

Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.

Mark S Link1, Douglas Laidlaw2, Bronislava Polonsky3, Wojciech Zareba3, Scott McNitt3, Kathleen Gear4, Frank Marcus4, N A Mark Estes2.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with sudden cardiac death. However, the selection of patients for implanted cardioverter-defibrillators (ICDs), as well as programming of the ICD, is unclear.
OBJECTIVES: The objective of this study was to identify predictors, characteristics, and treatment of ventricular arrhythmias in patients with ARVC.
METHODS: The Multidisciplinary Study of Right Ventricular Cardiomyopathy established the North American ARVC Registry and enrolled patients with a diagnosis of ARVC. Patients were followed prospectively.
RESULTS: Of 137 patients enrolled, 108 received ICDs. Forty-eight patients had 502 sustained episodes of ventricular arrhythmias, including 489 that were monomorphic and 13 that were polymorphic. In the patients with ICDs, independent predictors of ventricular arrhythmias in follow-up included spontaneous sustained ventricular arrhythmias before ICD implantation and T-wave inversions inferiorly. The only independent predictor for life-threatening arrhythmias, defined as sustained ventricular tachycardia (VT) ≥240 beats/min or ventricular fibrillation, was a younger age at enrollment. Anti-tachycardia pacing (ATP), independent of the cycle length of the VT, was successful in terminating 92% of VT episodes.
CONCLUSIONS: In the North American ARVC Registry, the majority of ventricular arrhythmias in follow-up are monomorphic. Risk factors for ventricular arrhythmias were spontaneous ventricular arrhythmias before enrollment and a younger age at ICD implantation. ATP is highly successful in terminating VT, and all ICDs should be programmed for ATP, even for rapid VT.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arrhythmogenic right ventricular cardiomyopathy; implantable cardioverter-defibrillator; ventricular arrhythmia; ventricular tachycardia

Mesh:

Substances:

Year:  2014        PMID: 25011714      PMCID: PMC4465360          DOI: 10.1016/j.jacc.2014.04.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

Authors:  Aditya Bhonsale; Cynthia A James; Crystal Tichnell; Brittney Murray; Dmitri Gagarin; Binu Philips; Darshan Dalal; Ryan Tedford; Stuart D Russell; Theodore Abraham; Harikrishna Tandri; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.

Authors:  Frank I Marcus; Wojciech Zareba; Hugh Calkins; Jeffrey A Towbin; Cristina Basso; David A Bluemke; N A Mark Estes; Michael H Picard; Danita Sanborn; Gaetano Thiene; Thomas Wichter; David Cannom; David J Wilber; Melvin Scheinman; Henry Duff; James Daubert; Mario Talajic; Andrew Krahn; Michael Sweeney; Hasan Garan; Scott Sakaguchi; Bruce B Lerman; Charles Kerr; Jack Kron; Jonathan S Steinberg; Duane Sherrill; Kathleen Gear; Mary Brown; Patricia Severski; Slava Polonsky; Scott McNitt
Journal:  Heart Rhythm       Date:  2009-03-11       Impact factor: 6.343

3.  Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators.

Authors:  M S Link; P J Wang; C J Haugh; M K Homoud; C B Foote; X B Costeas; N A Estes
Journal:  J Interv Card Electrophysiol       Date:  1997-02       Impact factor: 1.900

4.  Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.

Authors:  Gregory M Marcus; David V Glidden; Bronislava Polonsky; Wojciech Zareba; Lisa M Smith; David S Cannom; N A Mark Estes; Frank Marcus; Melvin M Scheinman
Journal:  J Am Coll Cardiol       Date:  2009-08-11       Impact factor: 24.094

5.  Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.

Authors:  Domenico Corrado; Hugh Calkins; Mark S Link; Loira Leoni; Stefano Favale; Michela Bevilacqua; Cristina Basso; Deirdre Ward; Giuseppe Boriani; Renato Ricci; Jonathan P Piccini; Darshan Dalal; Massimo Santini; Gianfranco Buja; Sabino Iliceto; N A Mark Estes; Thomas Wichter; William J McKenna; Gaetano Thiene; Frank I Marcus
Journal:  Circulation       Date:  2010-09-07       Impact factor: 29.690

6.  Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.

Authors:  K Lemola; C Brunckhorst; U Helfenstein; E Oechslin; R Jenni; F Duru
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

7.  Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.

Authors:  Stefan Peters
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2007-07       Impact factor: 2.160

8.  Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

Authors:  Kenneth A Ellenbogen; Joseph H Levine; Ronald D Berger; James P Daubert; Stephen L Winters; Eugene Greenstein; Alaa Shalaby; Andi Schaechter; Haris Subacius; Alan Kadish
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

Review 9.  Arrhythmogenic right ventricular cardiomyopathy.

Authors:  Cristina Basso; Domenico Corrado; Frank I Marcus; Andrea Nava; Gaetano Thiene
Journal:  Lancet       Date:  2009-04-11       Impact factor: 79.321

Review 10.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review.

Authors:  F I Marcus; G Fontaine
Journal:  Pacing Clin Electrophysiol       Date:  1995-06       Impact factor: 1.976

View more
  35 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 2.  Pregnancy in patients with implantable cardiac defibrillators.

Authors:  Geoffrey R Wong; Megan Ang; Jasveer Jayarajan; Fiona Walker; Pier D Lambiase
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-05-10

3.  Arrhythmogenic right ventricular cardiomyopathy (ARVC): case report and review of literature.

Authors:  Usha Rao; S Agarwal; T J Gilbert
Journal:  Heart Asia       Date:  2014-10-01

4.  Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators.

Authors:  Francesca Brun; Judith A Groeneweg; Kathleen Gear; Gianfranco Sinagra; Jeroen van der Heijden; Luisa Mestroni; Richard N Hauer; Mark Borgstrom; Frank I Marcus; Trina Hughes
Journal:  JACC Clin Electrophysiol       Date:  2016-06-01

5.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

6.  Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Tarek Zghaib; Mounes Aliyari Ghasabeh; Fabrizio R Assis; Jonathan Chrispin; Ali Keramati; Satish Misra; Ronald Berger; Hugh Calkins; Ihab Kamel; Saman Nazarian; Stefan Zimmerman; Harikrishna Tandri
Journal:  Circ Cardiovasc Imaging       Date:  2018-09       Impact factor: 7.792

7.  Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Authors:  Deniz Akdis; Corinna Brunckhorst; Firat Duru; Ardan M Saguner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 8.  Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.

Authors:  Alessandro Zorzi; Ilaria Rigato; Barbara Bauce; Kalliopi Pilichou; Cristina Basso; Gaetano Thiene; Sabino Iliceto; Domenico Corrado
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 9.  Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Hugh Calkins; Domenico Corrado; Frank Marcus
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

10.  Arrhythmogenic Right Ventricular Cardiomyopathy - Antiarrhythmic Therapy.

Authors:  Simon Ermakov; Melvin Scheinman
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.